HALISTER: Gilead Told to Pay Merck $2.54 Billion in Hepatitis C Royalties - Halister News

HALISTER: Gilead Told to Pay Merck $2.54 Billion in Hepatitis C Royalties

Gilead Told to Pay Merck $2.54 Billion in Hepatitis C Royalties

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
GILD US (Gilead Sciences Inc)
MRK US (Merck & Co Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

Download x-rimdevice-bloomberg-news-nlrt.blp